Roche Breast-Cancer Drug Shows Late-Stage Trial Success – Wall Street Journal


The Daily Star
Roche Breast-Cancer Drug Shows Late-Stage Trial Success
Wall Street Journal
By MARTA FALCONI ZURICH—Roche Holding AG Friday reported positive results from a late-stage study that compared its experimental breast cancer drug trastuzumab emtansine to a rival product from GlaxoSmithKline PLC, paving the way to file the potential
ImmunoGen Rises After Drug Delays Cancer Worsening in StudyBusinessWeek
Genentech, ImmunoGen 'Smart Bomb' for Breast Cancer Clears Big HurdleXconomy
Roche to file T-DM1 breast cancer drug on good dataReuters
Business Wire (press release) -Zacks.com
all 84 news articles »
This entry was posted in Health and tagged . Bookmark the permalink.

Comments are closed.